NORRETT KEVIN (Chief Business Officer) reported 1 transaction at SOLENO THERAPEUTICS INC
Review the transaction codes below to understand the nature of each event.
Filed: 5/18/2026ACC: 0001819690-26-000004
Officer· Chief Business Officer
Since Nov 2025
-86.07K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
86.07K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−17.79K
Price / share
—
Trade value
—
% of position
New position
5/18/2026
17.79K→0.00
Total
Net shares
−17.79K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/18/2026 | D · Disposition | −17.79K | — | — | New position | 17.79K | 0.00 |
| Total | −17.79K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to buy)
Direct
Converts to
Common Stock
64.29K shares
Shares
−64.29K
Strike price
47.25
Held after
0.00
Exercisable
—
5/18/2026
Stock Option (Right to buy)
Direct
Converts to
Common Stock
4K shares
Shares
−4K
Strike price
43.65
Held after
0.00
Exercisable
—
5/18/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Direct | Common Stock64.29K shares | 5/18/2026 | D · Disposition | −64.29K | 47.25 | — | 0.00 |
| Stock Option (Right to buy) Direct | Common Stock4K shares | 5/18/2026 | D · Disposition | −4K | 43.65 | — | 0.00 |